## Core Concept
The question tests knowledge on contrast-induced nephropathy (CIN) prevention, focusing on the safety profiles of various contrast media in patients with renal dysfunction. Contrast-induced nephropathy is a significant concern in radiology, particularly in patients with pre-existing renal impairment. The choice of contrast agent can influence the risk of CIN.

## Why the Correct Answer is Right
The correct answer, **. Iohexol**, is a low-osmolar, non-ionic contrast medium. Low-osmolar contrast media are known to have a lower risk of nephrotoxicity compared to high-osmolar agents. Among the options provided, Iohexol is recognized for its safety profile in patients with renal dysfunction, making it a suitable choice for preventing contrast nephropathy.

## Why Each Wrong Option is Incorrect
- **Option A:** Gadolinium-based contrast agents are primarily used in MRI and are not typically used for preventing contrast nephropathy in the context of CT scans or other procedures where iodinated contrast media are standard. Moreover, gadolinium can accumulate in tissues and has its own set of potential adverse effects, particularly in patients with significant renal impairment, leading to nephrogenic systemic fibrosis.
- **Option B:** High-osmolar contrast media are more nephrotoxic than low-osmolar agents and thus would not be the preferred choice for patients with renal dysfunction.
- **Option D:** This option might represent another type of contrast agent not specified due to formatting issues, but generally, the principle remains that low-osmolar, non-ionic agents like Iohexol are preferred for their lower nephrotoxicity.

## Clinical Pearl / High-Yield Fact
A key point to remember is that hydration is the cornerstone of preventing contrast-induced nephropathy, and the use of low-osmolar contrast agents can further reduce this risk. N-acetylcysteine and other antioxidants have been studied for their potential protective effects, but their use is less clear-cut. Always assess a patient's renal function before administering contrast media.

## Correct Answer: . Iohexol